Dr D Brockwell
Prof S E Radford
No more applications being accepted
Funded PhD Project (European/UK Students Only)
Protein aggregation is highly problematic to the £200bn biopharmaceutical industry as it can pose dangers to the patient (loss of efficacy of the protein drug and induction of the immune response) and can increase time-to-market and, therefore, cost of goods. Over the last four years, we have shown that fluid-driven forces can drive the aggregation of a small test protein (BSA) by triggering the exposure of new protein surfaces with greater self-affinity, leading to aggregation (see Dobson et al. (2017) Proc Natl Acad Sci USA. 114:4673-4678).
The flow induced aggregation pathway(s) of biopharmaceuticals such as IgGs, however, remain unexplored and consequently industry cannot reliably identify sequences that are inherently manufacturable. As antibody drug conjugates, next generation bi-specific platforms and gene therapy vectors are already posing an even greater manufacturing challenge, aggregation remains the major threat to the realisation of the enormous potentials of proteins in the bio-technology industry.
The goal of this BBSRC Collaborative Training Partnership PhD studentship between the Astbury Centre for Structural and Molecular Biology and Medimmune, therefore, is to apply Leeds’ unique expertise in protein (un)folding mechanisms, analytical mass spectrometry and hydrodynamic flow to identify the aggregation interfaces of antibodies provided by Medimmune.
To achieve this goal it is necessary to locate the aggregation interface and evaluate current or develop tools to allow their identification. This will be achieved by:
(i) measuring the flow-induced aggregation of a test set of scFvs that vary in their aggregation behaviour under different flow conditions.
(ii) assessing the ability of current bio-informatic approaches (such as SAP, CAMSOL and SOLUBIS) to predict the rank order of aggregation.
(iii) determining the mechanism of flow-induced unfolding. This will be achieved using a powerful combination of mass spectrometric and other labelling data to benchmark and / or constrain steered Molecular Dynamics simulations.
This fundamental study will ultimately facilitate the economic production of current and next generation high-value bio-pharmaceuticals.
BBSRC funded Medimmune Collaborative Training Partnership 4 year studentship.
Studentships covers UK/EU fees and stipend (c.£14,553) for 4 years to start in Oct 2018. Applicants should have/be expecting at least a 2.1 Hons. degree in a relevant subject. EU candidates require 3 years of UK residency in order to receive full studentship.
Please apply online here https://studentservices.leeds.ac.uk/pls/banprod/bwskalog_uol.P_DispLoginNon and include a CV and transcripts with your application.
Inducing protein aggregation by extensional flow. Dobson, J., Kumar, A., Willis, L., Tuma, R., R. Higazi, D., Turner, R., Lowe, D., Ashcroft, A., Radford, S., Kapur, N. and Brockwell, D. (2017) Proc Natl Acad Sci USA. 114:4673-4678.
How good is research at University of Leeds in Biological Sciences?
FTE Category A staff submitted: 60.90
Research output data provided by the Research Excellence Framework (REF)
Click here to see the results for all UK universities